MedPath

河南康达制药有限公司

Ownership
-
Established
2012-07-09
Employees
-
Market Cap
-
Website
http://www.kang-da.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

74

NMPA:74

Drug Approvals

Cefpirome Sulfate

Product Name
硫酸头孢匹罗
Approval Number
国药准字H20051151
Approval Date
Feb 7, 2024
NMPA

Ceftriaxone Sodium

Product Name
头孢曲松钠
Approval Number
国药准字H41021375
Approval Date
Jul 15, 2020
NMPA

Cefotaxime Sodium

Product Name
头孢噻肟钠
Approval Number
国药准字H41021376
Approval Date
Jul 15, 2020
NMPA

Cefoperazone Sodium

Product Name
头孢哌酮钠
Approval Number
国药准字H20033562
Approval Date
Jul 15, 2020
NMPA

Cefepime Hydrochloride

Product Name
盐酸头孢吡肟
Approval Number
国药准字H20052163
Approval Date
Jul 15, 2020
NMPA

Ciprofloxacin Hydrochloride

Product Name
盐酸环丙沙星
Approval Number
国药准字H41021377
Approval Date
Jul 3, 2019
NMPA

Valacyclovir Hydrochloride

Product Name
盐酸伐昔洛韦
Approval Number
国药准字H20064175
Approval Date
Jul 3, 2019
NMPA

Lansoprazole

Product Name
兰索拉唑
Approval Number
国药准字H20059147
Approval Date
Jul 3, 2019
NMPA

Sodium New Houttuyfonate

Product Name
新鱼腥草素钠
Approval Number
国药准字H20057155
Approval Date
Jul 3, 2019
NMPA

Levofloxacin Hydrochloride

Product Name
盐酸左氧氟沙星
Approval Number
国药准字H20057849
Approval Date
Jul 3, 2019
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 8
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.